Join us to learn about current research on how best to treat pain for people with non-NF2 related schwannomatosis. We’ll share information on the latest advancements in schwannomatosis pain research from the lab to the clinic, including information on the tanezumab and STARFISH clinical trials.
Vanessa Merker, PhD from Massachusetts General Hospital/Harvard Medical School will present, and take questions about clinical trials for schwannomatosis.
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.